CRW vs. EMIS, INS, KOO, RENX, COG, INHC, IQAI, FDBK, DVRG, and TRLS
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), and Trellus Health (TRLS). These companies are all part of the "health information services" industry.
Craneware vs.
Craneware (LON:CRW) and EMIS Group (LON:EMIS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, community ranking, risk, earnings, profitability, analyst recommendations and valuation.
Craneware has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, EMIS Group has a beta of -0.13, indicating that its stock price is 113% less volatile than the S&P 500.
Craneware pays an annual dividend of GBX 29 per share and has a dividend yield of 1.3%. EMIS Group pays an annual dividend of GBX 42 per share and has a dividend yield of 2.2%. Craneware pays out 11,153.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. EMIS Group is clearly the better dividend stock, given its higher yield and lower payout ratio.
EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 6.18%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.
EMIS Group has lower revenue, but higher earnings than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
EMIS Group received 13 more outperform votes than Craneware when rated by MarketBeat users. Likewise, 75.38% of users gave EMIS Group an outperform vote while only 71.69% of users gave Craneware an outperform vote.
Craneware currently has a consensus target price of GBX 2,700, suggesting a potential upside of 21.62%. Given Craneware's stronger consensus rating and higher possible upside, research analysts clearly believe Craneware is more favorable than EMIS Group.
60.2% of Craneware shares are owned by institutional investors. Comparatively, 105.6% of EMIS Group shares are owned by institutional investors. 19.3% of Craneware shares are owned by insiders. Comparatively, 3.6% of EMIS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, EMIS Group had 1 more articles in the media than Craneware. MarketBeat recorded 2 mentions for EMIS Group and 1 mentions for Craneware. Craneware's average media sentiment score of 0.75 beat EMIS Group's score of -0.38 indicating that Craneware is being referred to more favorably in the media.
Summary
EMIS Group beats Craneware on 12 of the 20 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
This page (LON:CRW) was last updated on 11/21/2024 by MarketBeat.com Staff
